Erytech Pharma (ERYP) Succumbs to Corrections Premarket After Upsurge on Manufacturing Facility Sale
Yesterday, the biotech company, Erytech Pharma (ERYP) announced the sale of its manufacturing facility in the U.S. Following the news, the stock surged up by a nice 37.70% as investors responded positively to the huge transaction. Closing the day at $1.68 a share, ERYP has fallen under corrections in today’s premarket on April 26, 2022. …